Bariatric surgery is effective rescue strategy after GLP-1 receptor agonist failure
Bariatric surgery is associated with clinically meaningful two-year weight loss after semaglutide or tirzepatide intolerance or inadequate response, according to a study published online Nov. 3 in the Annals of Surgery.
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
South African trial tests off-the-shelf killer cells against lymphoma
United Kingdom
-
Is shorter daylight dragging down your mood? What to know about seasonal affective disorder
United Kingdom
-
The Cybertruck's 'cause of death?' Insufficient demand
United States
-
This was the week the AI trade cracked. So what's next?
United States
-
AI better assesses heart function from MRI than clinicians
United Kingdom
-
People Around the World Help Buy Royal Estate for Wildlife Conservation
United Kingdom
-
Platform finds hidden flaws in athletes' form
United Kingdom
-
Rising grocery prices linked to higher food anxiety and insufficiency
United Kingdom